Elicio Therapeutics (ELTX) Current Leases (2021 - 2026)
Elicio Therapeutics' (ELTX) quarterly Current Leases came in at $1.0 million in Q1 2026, up 12.53% YoY from $926000.0 in Q1 2025, and up 3.07% on a QoQ basis from $1.0 million in Q4 2025.
Elicio Therapeutics (ELTX) Current Leases (2021 - 2026) Analysis & Trends
Elicio Therapeutics (ELTX) has 6 years of Current Leases data on file, last reported at $1.0 million in Q1 2026.
- Quarterly Current Leases rose 12.53% year-over-year to $1.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.0 million (up 12.53% YoY) and the FY2025 annual result came in at $1.0 million, up 12.21% from the prior year.
- Current Leases advanced to $1.0 million in Q1 2026, from $1.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.0 million in Q1 2026 to a low of $62000.0 in Q2 2022.
- A 5-year average of $777705.9 and a median of $910000.0 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2022 — Current Leases plunged 92.68% — and 2023, when it surged 1488.71%.
- Tracing ELTX's Current Leases over 5 years: stood at $692000.0 in 2022, then soared by 31.5% to $910000.0 in 2023, then fell by 0.99% to $901000.0 in 2024, then gained by 12.21% to $1.0 million in 2025, then rose by 3.07% to $1.0 million in 2026.
- The last three Current Leases figures came in at $1.0 million (Q1 2026), $1.0 million (Q4 2025), and $981000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 45.93 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Elicio Therapeutics | 58.41 Mn | 34.91 Mn | - | 1.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.04 Mn |
| Dec 31, 2025 | 1.01 Mn |
| Sep 30, 2025 | 981,000.00 |
| Jun 30, 2025 | 952,000.00 |
| Mar 31, 2025 | 926,000.00 |
| Dec 31, 2024 | 901,000.00 |
| Sep 30, 2024 | 877,000.00 |
| Jun 30, 2024 | 854,000.00 |
| Mar 31, 2024 | 881,000.00 |
| Dec 31, 2023 | 910,000.00 |
| Sep 30, 2023 | 938,000.00 |
| Jun 30, 2023 | 985,000.00 |
| Mar 31, 2023 | 227,000.00 |
| Dec 31, 2022 | 692,000.00 |
| Sep 30, 2022 | 64,000.00 |
| Jun 30, 2022 | 62,000.00 |
| Mar 31, 2022 | 918,000.00 |
| Dec 31, 2021 | 894,000.00 |
| Sep 30, 2021 | 870,000.00 |